Abstract
The public health emergency for coronavirus disease 2019 ended on April 11, 2023, 1 month earlier than its planned termination. The hasty cessation of emergency measures may negatively impact the care of solid organ transplant recipients and other immunosuppressed hosts. Accelerated pathways for drug and vaccine approvals, research funding, and insurance coverage for medical therapies and diagnostic testing are likely to be affected. Health care disparities that characterized the early pandemic may again be intensified. It is imperative that the transplant community promptly anticipate the impact of these changes and prepare accordingly to avoid disruptions in care for the most vulnerable patients.
Original language | English (US) |
---|---|
Pages (from-to) | 1507-1510 |
Number of pages | 4 |
Journal | American Journal of Transplantation |
Volume | 23 |
Issue number | 10 |
DOIs | |
State | Published - Oct 2023 |
Keywords
- COVID-19
- public health emergency
- vaccination
ASJC Scopus subject areas
- Immunology and Allergy
- Transplantation
- Pharmacology (medical)